orapaz

orapaz
SPL v1
SPL
SPL Set ID 2de0b332-58a3-0bb4-e063-6394a90a1a45
Routes
dental oral
Published
Effective Date 2025-02-10
Document Type 34391-3 HUMAN PRESCRIPTION DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
chlorhexidine (1.2 mg) cephalexin anhydrous (500 mg) ibuprofen (800 mg)
Inactive Ingredients
alcohol glycerin water fd&c blue no. 1 saccharin sodium peg-40 sorbitan diisostearate titanium dioxide microcrystalline cellulose sodium lauryl sulfate magnesium stearate d&c yellow no. 10 gelatin, unspecified croscarmellose sodium fd&c yellow no. 6 stearic acid polyethylene glycol, unspecified sodium starch glycolate type a potato silicon dioxide starch, corn talc

Identifiers & Packaging

Pill Appearance
Imprint: BI8 Shape: capsule Shape: oval Color: blue Color: green Color: white Size: 21 mm Size: 19 mm Score: 1
Marketing Status
unapproved drug other active Since 2025-02-10

Description

Rx Only NDC 73614-417-03 ORAPAZ™ Each Pack Contains: Cephalexin Capsules, USP 500 mg - One 30 ct Bottle Ibuprofen Tablets, USP 800 mg - One 30 ct Bottle Chlorhexidine Gluconate Oral Rinse, USP 0.12% - Two 118 ml Bottles Brisk Pharmaceuticals


Medication Information

Description

Rx Only

NDC 73614-417-03

ORAPAZ™

Each Pack Contains:


Cephalexin Capsules, USP 500 mg - One 30 ct Bottle

Ibuprofen Tablets, USP 800 mg - One 30 ct Bottle

Chlorhexidine Gluconate Oral Rinse, USP 0.12% - Two 118 ml Bottles

Brisk Pharmaceuticals

Section 51945-4


Structured Label Content

Description (34089-3)

Rx Only

NDC 73614-417-03

ORAPAZ™

Each Pack Contains:


Cephalexin Capsules, USP 500 mg - One 30 ct Bottle

Ibuprofen Tablets, USP 800 mg - One 30 ct Bottle

Chlorhexidine Gluconate Oral Rinse, USP 0.12% - Two 118 ml Bottles

Brisk Pharmaceuticals

Section 51945-4 (51945-4)


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)